|
ION-1 NAIVES & ION-2 Treatment-Exp SVR Rates - RBV Cirrhotics/Ethnicity/ baseline NS5A resistance
|
|
|
In ION-1 there appears no affect of with or without Rbv or 12 vs 24 weeks. But look below to ION-2 for differences.
![ICAAC1.gif](../images/091714/091714-1/ICAAC1.gif)
![ICAAC2.gif](../images/091714/091714-1/ICAAC2.gif)
ION-2 TREAT-Exp
Certain patient subgroups show a lower SVR rate without Rbv & with 12 weeks. Gt1b 2/23 87% had SVR without Rbv vs 23/23 100% with Rbv for 12 wks, but SVR rate was 100% with 24 weeks. Patients with cirrhosis had 85% w/o Rbv & 81% with Rbv with 12 weeks vs 100% (22/22 & 22/22, respectively) with 24 weeks. Ethnicity- blacks & latinos did the same with/without Rbv 12 or 24 weeks. Patients with prior therapy had better SVR rates with 24 weeks, particularly those with cirrhosis & prior experience.
![ICAAC3.gif](../images/091714/091714-1/ICAAC3.gif)
![ICAAC4.gif](../images/091714/091714-1/ICAAC4.gif)
![ICAAC5.gif](../images/091714/091714-1/ICAAC5.gif)
![ICAAC6.gif](../images/091714/091714-1/ICAAC6.gif)
|
|
|
|
|
|
|